You are here: Industry Insights > definitive agreement

News List

Dr. Reddy's enters into a definitive agreement to sell its neurology branded products to Upsher Smith Laboratories biospectrumasia
June 16, 2019
Under the agreement, Dr. Reddy’s will receive U.S.$70 million as upfront consideration, U.S.$40.5 million in near term milestones and additional financial considerations including existing contractual obligation and inventory.
Aposense has signed a definitive agreement with SirVir Ltd. A private company, jointly owned by Aposense, Prof. Roger D. Kornberg, and Access Industries Holdings LLC. firstwordpharma
January 10, 2019
Concurrently with the execution of the license agreement, a share purchase agreement was executed between the Company and Access whereby the latter will invest in the Subsidiary, in two stages, $ 20 million in return for preferred shares in the Subsidiary
Juniper Signs Definitive Agreement to be acquired by Catalent americanpharmaceuticalreview
July 11, 2018
Juniper Pharmaceuticals has entered into a definitive agreement with Catalent to acquire all of the outstanding shares of Juniper at a price of $11.50 per share in cash.